Xenetic Logo

4-0.jpg
  • Home
  • About Us
  • Science & Technology
  • Product Pipeline
  • Investor Relations
    • Rule 26
    • RNS News
    • Shareholder information
    • News & Media
    • Events calendar
    • Corporate Governance
    • Financial reports
    • Advisors
    • Articles of Association
    • FAQs
  • Careers
Investor Relations
FAQs
What does Xenetic do?

Xenetic researches, develops and manufactures biopharmaceuticals: protein-based drugs for the treatment of human and veterinary diseases. 

Who is on the Board of Directors?

Please go to our Directors page to see the full list of directors

Which products are currently under development?

We have a number of products under development.

How long has Xenetic been listed as a public company?

Xenetic was admitted to AIM (originally as Lipoxen plc) on 17th January 2006

 

What is the trading ticker for the company?

XEN

Do the shares trade on any other stock exchange?

No

When does Xenetic report its results?

As a public company, we report our results twice a year and these dates will be published in advance on our website

 

How can I obtain a copy of the Company's annual report?

There are electronic versions of all the Company's financial reports in the Investor Centre section of the website.  Hard copies can be obtained on request.

 
  • Sitemap
  • Accessibility
  • Terms and Conditions
  • Error
EmailPrint

Xenetic Biosciences plc © 2011 Designed and developed by Emperor